1. Home
  2. TWST vs CMBT Comparison

TWST vs CMBT Comparison

Compare TWST & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • CMBT
  • Stock Information
  • Founded
  • TWST 2013
  • CMBT 1989
  • Country
  • TWST United States
  • CMBT Belgium
  • Employees
  • TWST N/A
  • CMBT N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • CMBT
  • Sector
  • TWST Health Care
  • CMBT
  • Exchange
  • TWST Nasdaq
  • CMBT NYSE
  • Market Cap
  • TWST 1.8B
  • CMBT 1.7B
  • IPO Year
  • TWST 2018
  • CMBT N/A
  • Fundamental
  • Price
  • TWST $38.17
  • CMBT $9.42
  • Analyst Decision
  • TWST Buy
  • CMBT
  • Analyst Count
  • TWST 10
  • CMBT 0
  • Target Price
  • TWST $49.10
  • CMBT N/A
  • AVG Volume (30 Days)
  • TWST 1.0M
  • CMBT 88.2K
  • Earning Date
  • TWST 08-01-2025
  • CMBT 08-07-2025
  • Dividend Yield
  • TWST N/A
  • CMBT 10.90%
  • EPS Growth
  • TWST N/A
  • CMBT N/A
  • EPS
  • TWST N/A
  • CMBT 2.16
  • Revenue
  • TWST $347,680,000.00
  • CMBT $934,913,000.00
  • Revenue This Year
  • TWST $22.58
  • CMBT $5.05
  • Revenue Next Year
  • TWST $17.71
  • CMBT $24.22
  • P/E Ratio
  • TWST N/A
  • CMBT $4.41
  • Revenue Growth
  • TWST 25.30
  • CMBT N/A
  • 52 Week Low
  • TWST $27.12
  • CMBT $7.65
  • 52 Week High
  • TWST $60.90
  • CMBT $18.43
  • Technical
  • Relative Strength Index (RSI)
  • TWST 63.09
  • CMBT 54.83
  • Support Level
  • TWST $35.88
  • CMBT $9.15
  • Resistance Level
  • TWST $38.86
  • CMBT $9.75
  • Average True Range (ATR)
  • TWST 1.87
  • CMBT 0.23
  • MACD
  • TWST 0.32
  • CMBT -0.02
  • Stochastic Oscillator
  • TWST 84.05
  • CMBT 67.45

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About CMBT EURONAV

CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organizes itself into three divisons: the Marine division, the H2 Infra division and the H2 Industry division. The Marine Division derives maximum revenue.

Share on Social Networks: